Artificial intelligence for the real-time classification of intrapapillary capillary loop patterns in the endoscopic diagnosis of early oesophageal squamous cell carcinoma: A proof-of-concept study.
Artificial intelligence
computer-aided diagnosis
endoscopy
neural networks
oesophageal cancer
squamous cell cancer
Journal
United European gastroenterology journal
ISSN: 2050-6406
Titre abrégé: United European Gastroenterol J
Pays: England
ID NLM: 101606807
Informations de publication
Date de publication:
03 2019
03 2019
Historique:
received:
04
10
2018
accepted:
26
11
2018
entrez:
14
5
2019
pubmed:
14
5
2019
medline:
14
5
2019
Statut:
ppublish
Résumé
Intrapapillary capillary loops (IPCLs) represent an endoscopically visible feature of early squamous cell neoplasia (ESCN) which correlate with invasion depth - an important factor in the success of curative endoscopic therapy. IPCLs visualised on magnification endoscopy with Narrow Band Imaging (ME-NBI) can be used to train convolutional neural networks (CNNs) to detect the presence and classify staging of ESCN lesions. A total of 7046 sequential high-definition ME-NBI images from 17 patients (10 ESCN, 7 normal) were used to train a CNN. IPCL patterns were classified by three expert endoscopists according to the Japanese Endoscopic Society classification. Normal IPCLs were defined as type A, abnormal as B1-3. Matched histology was obtained for all imaged areas. This CNN differentiates abnormal from normal IPCL patterns with 93.7% accuracy (86.2% to 98.3%) and sensitivity and specificity for classifying abnormal IPCL patterns of 89.3% (78.1% to 100%) and 98% (92% to 99.7%), respectively. Our CNN operates in real time with diagnostic prediction times between 26.17 ms and 37.48 ms. Our novel and proof-of-concept application of computer-aided endoscopic diagnosis shows that a CNN can accurately classify IPCL patterns as normal or abnormal. This system could be used as an in vivo, real-time clinical decision support tool for endoscopists assessing and directing local therapy of ESCN.
Sections du résumé
Background
Intrapapillary capillary loops (IPCLs) represent an endoscopically visible feature of early squamous cell neoplasia (ESCN) which correlate with invasion depth - an important factor in the success of curative endoscopic therapy. IPCLs visualised on magnification endoscopy with Narrow Band Imaging (ME-NBI) can be used to train convolutional neural networks (CNNs) to detect the presence and classify staging of ESCN lesions.
Methods
A total of 7046 sequential high-definition ME-NBI images from 17 patients (10 ESCN, 7 normal) were used to train a CNN. IPCL patterns were classified by three expert endoscopists according to the Japanese Endoscopic Society classification. Normal IPCLs were defined as type A, abnormal as B1-3. Matched histology was obtained for all imaged areas.
Results
This CNN differentiates abnormal from normal IPCL patterns with 93.7% accuracy (86.2% to 98.3%) and sensitivity and specificity for classifying abnormal IPCL patterns of 89.3% (78.1% to 100%) and 98% (92% to 99.7%), respectively. Our CNN operates in real time with diagnostic prediction times between 26.17 ms and 37.48 ms.
Conclusion
Our novel and proof-of-concept application of computer-aided endoscopic diagnosis shows that a CNN can accurately classify IPCL patterns as normal or abnormal. This system could be used as an in vivo, real-time clinical decision support tool for endoscopists assessing and directing local therapy of ESCN.
Identifiants
pubmed: 31080614
doi: 10.1177/2050640618821800
pii: 10.1177_2050640618821800
pmc: PMC6498793
doi:
Types de publication
Journal Article
Research Support, Non-U.S. Gov't
Langues
eng
Pagination
297-306Subventions
Organisme : Medical Research Council
ID : MC_PC_17180
Pays : United Kingdom
Organisme : Wellcome Trust
ID : 203145Z/16/Z
Pays : United Kingdom
Organisme : Wellcome Trust
ID : WT101957
Pays : United Kingdom
Références
Cancer Epidemiol Biomarkers Prev. 2013 Apr;22(4):540-52
pubmed: 23549398
Esophagus. 2017;14(2):105-112
pubmed: 28386209
Gastroenterol Clin North Am. 2009 Mar;38(1):17-25, vii
pubmed: 19327565
J Biomed Opt. 2004 May-Jun;9(3):568-77
pubmed: 15189095
Ann Gastroenterol. 2015 Jan-Mar;28(1):41-48
pubmed: 25608626
Endoscopy. 2015 Feb;47(2):122-8
pubmed: 25590187
World J Gastroenterol. 2013 Sep 14;19(34):5598-606
pubmed: 24039351
Dig Endosc. 2010 Oct;22(4):259-67
pubmed: 21175477
Oncol Rep. 2011 Nov;26(5):1063-7
pubmed: 21785826
Expert Rev Anticancer Ther. 2011 Apr;11(4):601-12
pubmed: 21504265
Gastrointest Endosc Clin N Am. 2010 Jan;20(1):25-34, v-vi
pubmed: 19951792
J Gastroenterol Hepatol. 2018 Jun;33(6):1248-1255
pubmed: 29247549
World J Gastroenterol. 2017 Jun 28;23(24):4416-4421
pubmed: 28706424
Surgery. 1998 Apr;123(4):432-9
pubmed: 9551070
Endosc Int Open. 2014 Jun;2(2):E46-50
pubmed: 26135259
Clin Gastroenterol Hepatol. 2005 Jul;3(7 Suppl 1):S67-70
pubmed: 16013002
Gut. 2000 Aug;47(2):251-5
pubmed: 10896917
Gastrointest Endosc. 2002 Sep;56(3):387-90
pubmed: 12196777
Clin Endosc. 2014 Nov;47(6):523-9
pubmed: 25505718
World J Surg. 2006 Aug;30(8):1441-9
pubmed: 16871357